Please login to the form below

Not currently logged in
Email:
Password:

Nycomed in BT HP deal

Nycomed has signed a new five-year communications and IT deal with BT and Hewlett Packard to outsource its infrastructure
Nycomed has signed a new five-year communications and IT deal with BT and Hewlett Packard (HP) to outsource its infrastructure.

Swiss pharmaceutical company Nycomed choose the BT HP alliance to manage over 450 of its servers and 10,000 workstations across 50 countries. Nycomed's technology infrastructure will be outsourced to BT and HP to help facilitate rapid dissemination of information critical to the company.

Agnetha Mattisson, senior vice-president of corporate IS/IT for the privately owned pharma company, said: "Together we will establish a robust and scalable environment that will support Nycomed's goals to grow the business."

"Nycomed is taking advantage of the BT HP alliance's economies of scale, skilled staff and industrialisation of operations," Mattisson added.

Ann Livermore, executive vice president of technology solutions group for HP, said: "We are honoured to be selected by Nycomed as a trusted partner and we look forward to helping them manage and transform their infrastructure into an asset for business and competitive advantage."

Nycomed's presence in approximately 50 markets globally and its acquisition of German based Atlanta Pharma in 2007 makes it one of the 25 largest pharmaceutical companies in the world.

9th April 2008

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Porterhouse Medical Group

The Porterhouse Medical Group provides market research, insights, and scientific and medical communication services to the pharmaceutical industry across the...

Latest intelligence

image 1
Redefining communications excellence
How to be heard in today’s multichannel, multistakeholder, multimedia world...
AZ Campus
AstraZeneca: building a new ‘open innovation’ pharma company
The construction of its new HQ has suffered some serious delays, but new R&D and commercial success are lifting AstraZeneca’s prospects...
Erik Nordkamp
In conversation with Pfizer’s Erik Nordkamp
Pfizer’s UK general manager talks to PME about the NHS at 70, the potential of pharma partnerships and some lessons from Europe...

Infographics